These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 11688500)

  • 41. Non-steroidal anti-inflammatory drug-induced gastroduodenal toxicity and Helicobacter pylori.
    Wardi J; Shirin H
    Isr Med Assoc J; 2003 Mar; 5(3):195-7. PubMed ID: 12725142
    [No Abstract]   [Full Text] [Related]  

  • 42. Eradicate the bug before you start the drug?
    Metz DC
    Am J Gastroenterol; 1998 Feb; 93(2):279-80. PubMed ID: 9468265
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Salentijn GJ
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2340. PubMed ID: 10589227
    [No Abstract]   [Full Text] [Related]  

  • 44. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of Helicobacter pylori-positive peptic ulcer disease.
    Malfertheiner P
    Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
    [No Abstract]   [Full Text] [Related]  

  • 46. [Relationship between NSAIDs and H. pylori in peptic ulcer diseases--is the eradication of H. pylori recommended in NSAIDs ulcer?].
    Ota S; Nakajima S; Bamba H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():565-8. PubMed ID: 16363602
    [No Abstract]   [Full Text] [Related]  

  • 47. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Eradication of Helicobacter pylori and use of antisecretory drugs--a population based study].
    Lassen AT; Hallas J; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2004 Sep; 166(39):3405-7. PubMed ID: 15515395
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current criteria for the treatment of peptic ulcer].
    Díaz-Rubio García DM
    An R Acad Nac Med (Madr); 1996; 113(1):213-21; discussion 221-5. PubMed ID: 8967574
    [No Abstract]   [Full Text] [Related]  

  • 52. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

  • 53. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease.
    Chiorean MV; Locke GR; Zinsmeister AR; Schleck CD; Melton LJ
    Am J Gastroenterol; 2002 Dec; 97(12):3015-22. PubMed ID: 12492184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [NSAID-gastropathy and Helicobacter pylori: more questions than answers].
    Shirinskaia NV; Akhmedov VA
    Eksp Klin Gastroenterol; 2010; (9):116-20. PubMed ID: 21427936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cause-targeted treatment of ulcer disease].
    Seppälä K; Sipponen P; Palmu A
    Duodecim; 1994; 110(20):1853-9. PubMed ID: 7555798
    [No Abstract]   [Full Text] [Related]  

  • 56. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Helicobacter pylori and non-steroidal anti-inflammatory drugs: ulcers and bleeding ulcers.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):116-8. PubMed ID: 10363195
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
    Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
    Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Helicobacter pylori infection.
    Ebell MH
    J Fam Pract; 1996 Jun; 42(6):568. PubMed ID: 8656165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.